John Hawley

Call for submissions: ASCI member host labs, 2025–2027

Posted on by John Hawley

As part of the ASCI’s Postbac Program, the ASCI is pleased to call for submissions from Society members who are interested in their labs serving as hosts for Program finalists for 2025–2027.

Any member can provide a submission by:

The deadline for submissions is March 3, 2025, 11:59 pm Eastern.

Submissions consist of the following sections:

  • Your information
    • Your institution
    • Your trainee table (PDF upload)
  • About your lab
    • Lab website
    • Lab description and environment (500-word limit). Provide detail on mentoring awards, motivation for applying, and mentorship plan (what presentation will be expected, feedback provided, and participation).
    • Lab member who would be assigned for day-to-day mentoring of the postbac (name, position)
    • Assignee’s biosketch (PDF upload)
  • Institutional resources
    • Provide detail on aspects such as the requisite amount of bench/desk space in lab, faculty member to work with the student on medical-school essay, institutional career development, and educational and networking opportunities.
    • Institutional stipend levels. The ASCI expects stipends to fall within the ranges of the NIH post-bac IRTA program, with the understanding that the cost of living ranges widely depending on location. Provide information for 2025–2026 and 2026–2027.
    • Indicate if you are able to supplement beyond your institution’s stipend amounts or beyond the ASCI’s maximum grant of $55,000 ($50,000 direct; $5,000 indirect).

Nominations for ASCI Council, 2025

Posted on by John Hawley

The Society seeks nominations for the following ASCI Council vacancies arising in 2025 (all terms begin and end in the spring):

  • Vice President (4-year term, 2025-2029)
  • Councilor (2 positions, 3-year term, 2025-2028)

Those eligible for nomination must be in the Active category and:

  • for Vice President, do not turn 56 until 2030 or later
  • for Councilor, do not turn 56 until 2029 or later

The Society strongly encourages members to consider diversity in identifying those suitable for nomination. Self-nominations are not permitted. Nominations may be submitted by any member in good standing (with dues up to date if applicable) and must be submitted by February 14, 2025, at 11:59 PM EST.

All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, with the spring meeting occurring as part of the annual meeting) and videoconference calls (typically every other month). All Council members participate in the review of membership and various award nominations and subsequent discussion at the fall meeting.

The Vice President transitions to President-Elect in year 2, President in year 3, and Immediate Past President in year 4. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the annual meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program and presents the traditional Presidential Address at the meeting.

The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

Nominators:

  • may be any ASCI member
  • must provide a statement (250-word limit) regarding the nominee

Nominees:

  • must specify the position of interest (Vice President, Councilor);
  • provide a 250-word candidate statement, written in first person, for consideration by the Council and for use as the ballot statement if the nominee is selected as a candidate (nominees may refer to candidate statements for the 2024 nomination cycle for guidance in drafting their own statements);
  • provide an NIH-style biosketch;
  • must complete the ASCI’s demographic survey and provide information about research domain(s).

To start a nomination:

  • In the section for “Council vacancies”:
    • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
    • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

      • Access your member account
      • Go to the “Nominations” tab
      • In the section for “Council vacancies”:
        • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information).
        • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who are within the age-eligibility criteria will be returned in the results.

      The ASCI’s 2025 Active and International elected members

      Posted on by John Hawley

      The ASCI is pleased to announce the election of 99 Active and International members for 2025.

      These new members come from 46 different institutions and represent excellence across the breadth of academic medicine. They will be officially inducted into the Society at the ASCI Dinner and New Member Induction Ceremony, April 25, 2025, as part of the AAP/ASCI/APSA Joint Meeting, April 25–27, at the Swissotel Chicago.

      Active and International members, 2025

      Daniel Addison, MD
      Ohio State University College of Medicine
      Sally Nneoma Sarah Adebamowo, MBBS, MSc, ScD
      University of Maryland School of Medicine
      Manmeet Singh Ahluwalia, MD, MBA
      Florida International University
      Niroshana Anandasabapathy, MD, PhD
      Weill Cornell Medicine
      Jason Randolph Andrews, MD
      Stanford University School of Medicine
      Saro H. Armenian, DO, MPH
      City of Hope Medical Center
      Pratiti Bandopadhayay, MBBS, PhD
      Harvard Medical School, Dana-Farber Cancer Institute
      Alexander G. Bick, MD, PhD
      Vanderbilt University Medical Center
      Ranjit S. Bindra, MD, PhD
      Yale School of Medicine
      Eli A. Boritz, MD, PhD
      NIH, National Institute of Allergy and Infectious Diseases (NIAID)
      David A. Braun, MD, PhD
      Yale School of Medicine
      Joshua D. Brody, MD
      Icahn School of Medicine at Mount Sinai
      Cesar Martin Castro, MD, MS, MMSc
      Harvard Medical School, Massachusetts General Hospital
      Andrea Cercek, MD
      Memorial Sloan Kettering Cancer Center
      Rohit Chandwani, MD, PhD
      Weill Cornell Medicine
      Daniel I-Hsin Chu, MD, MSPH, FACS, FASCRS
      University of Alabama at Birmingham School of Medicine
      Nicole G. Coufal, MD, PhD
      University of California, San Diego, School of Medicine
      Mucio Kit Delgado, MD, MS
      University of Pennsylvania Perelman School of Medicine
      Rajat Deo, MD, MTR
      University of Pennsylvania Perelman School of Medicine
      Jörg Hans Wilhelm Distler, MD
      Heinrich-Heine-University Duesseldorf
      Michael Thomas Eadon, MD
      Indiana University School of Medicine
      Yi Fan, MD, PhD
      University of Pennsylvania Perelman School of Medicine
      Mariella G. Filbin, MD, PhD
      Harvard Medical School, Dana-Farber Cancer Institute
      Terence Peter Gade, MD, PhD
      University of Pennsylvania Perelman School of Medicine
      Ethan M. Goldberg, MD, PhD
      Children’s Hospital of Philadelphia
      Misty Good, MD, MS
      University of North Carolina School of Medicine
      Madhusudan Grover, MBBS
      Mayo Clinic
      Rajat M. Gupta, MD
      Harvard Medical School, Brigham & Women’s Hospital
      Lida P. Hariri, MD, PhD
      Harvard Medical School, Massachusetts General Hospital
      Takashi Hato, MD
      Indiana University School of Medicine
      Jorge Henao-Mejia, MD, PhD
      University of Pennsylvania Perelman School of Medicine
      Angela Christine Hirbe, MD, PhD
      Washington University School of Medicine in St. Louis
      Lori Rachel Holtz, MD, MSPH
      Washington University School of Medicine in St. Louis
      William Tzu-lung Hu, MD, PhD, FAAN
      Rutgers, Robert Wood Johnson Medical School
      Alison Ju-Tsu Huang, MD, MAS
      University of California, San Francisco, School of Medicine
      Jason T. Huse, MD, PhD
      University of Texas MD Anderson Cancer Center
      Tamara Isakova, MD, MMSc
      Northwestern University Feinberg School of Medicine
      Prasanna Jagannathan, MD
      Stanford University School of Medicine
      Tobias Janowitz, MBBChir, PhD
      Cold Spring Harbor Laboratory
      Robert R. Jenq, MD
      City of Hope Medical Center
      Wen Jiang, MD, PhD
      University of Texas MD Anderson Cancer Center
      Sadiya Sana Khan, MD, MSc
      Northwestern University Feinberg School of Medicine
      John B. Kisiel, MD, MS
      Mayo Clinic
      Jeffery M. Klco, MD, PhD
      St. Jude Children’s Research Hospital
      Liza (Yelizaveta) Konnikova, MD, PhD
      Yale School of Medicine
      Jonathan Andrew Kropski, MD
      Vanderbilt University School of Medicine
      Hrishikesh S. Kulkarni, MD, MSCI
      University of California, Los Angeles, David Geffen School of Medicine
      Sonia S. Kupfer, MD
      University of Chicago Pritzker School of Medicine
      Angelle Desiree LaBeaud, MD, MS
      Stanford University School of Medicine
      Anne C.C. Lee, MD, MPH
      Brown University Medical School
      Katherine Phoenix Liao, MD, MPH
      Harvard Medical School, Brigham & Women’s Hospital
      Robbie G. Majzner, MD
      Harvard Medical School, Dana-Farber Cancer Institute
      Rajeev Malhotra, MD, MA
      Harvard Medical School, Massachusetts General Hospital
      Joseph D. Mancias, MD, PhD
      Harvard Medical School, Dana-Farber Cancer Institute
      Nilam S. Mangalmurti, MD
      University of Pennsylvania Perelman School of Medicine
      Folasade P. May, MD, PhD, MPhil
      University of California, Los Angeles, David Geffen School of Medicine
      Megan E. McNerney, MD, PhD
      University of Chicago Pritzker School of Medicine
      Jaimie P. Meyer, MD, MS, FACP
      Yale School of Medicine
      Derek P. Narendra, MD, PhD
      National Institutes of Health
      Brian Timothy O’Neill, MD, PhD
      University of Iowa Carver College of Medicine
      Stephen T. Oh, MD, PhD
      Washington University School of Medicine in St. Louis
      Opeyemi A. Olabisi, MD, PhD
      Duke University School of Medicine
      Matthew G. Oser, MD, PHD
      Harvard Medical School, Dana-Farber Cancer Institute
      Eric Padron, MD
      Moffitt Cancer Center
      Akash Patnaik, MD, PhD, MMSc
      University of Chicago Pritzker School of Medicine
      Tien Peng, MD
      University of California, San Francisco, School of Medicine
      Paige M. Porrett, MD, PhD
      University of Alabama at Birmingham School of Medicine
      Camille E. Powe, MD
      Harvard Medical School, Massachusetts General Hospital
      David R. Raleigh, MD, PhD
      University of California, San Francisco, School of Medicine
      Deepak A. Rao, MD, PhD
      Harvard Medical School, Brigham & Women’s Hospital
      Meenakshi Rao, MD, PhD
      Harvard Medical School, Boston Children’s Hospital
      Abby Rachel Rosenberg, MD, MS, MA
      Harvard Medical School, Dana-Farber Cancer Institute
      Kathryn J. Ruddy, MD
      Mayo Clinic
      Elias Joseph Sayour, MD, PhD
      University of Florida College of Medicine
      Philip Oliver Scumpia, MD, PhD
      University of California, Los Angeles, David Geffen School of Medicine
      Chetan Seshadri, MD
      University of Washington School of Medicine
      Nilay Sethi, MD, PhD
      Harvard Medical School, Dana-Farber Cancer Institute
      Nirali N. Shah, MD, MHSc
      NIH, National Cancer Institute (NCI)
      Keith Magnus Sigel, MD, PhD, MPH
      Icahn School of Medicine at Mount Sinai
      Emily K. Sims, MD
      Indiana University School of Medicine
      Zirui Song, MD, PhD
      Harvard Medical School, Massachusetts General Hospital
      Tomokazu Souma, MD, PhD
      Duke University School of Medicine
      Kathryn Elaine Stephenson, MD, MPH
      Harvard Medical School, Beth Israel Deaconess Medical Center
      Sean Robinson Stowell, MD, PhD
      Harvard Medical School, Brigham & Women’s Hospital
      Paul C. Tang, MD, PhD
      Mayo Clinic
      Justin Taylor, MD
      University of Miami Miller School of Medicine
      Marmar Vaseghi, MS, MD, PhD
      University of California, Los Angeles, David Geffen School of Medicine
      Elizabeth C. Verna, MD, MSc, FAASLD, FAST
      Columbia University Vagelos College of Physicians and Surgeons
      Srinivas Raghavan Viswanathan, MD, PhD
      Harvard Medical School, Dana-Farber Cancer Institute
      Daniel R. Wahl, MD, PhD
      University of Michigan Medical School
      Amisha Wallia, MD, MS
      Northwestern University Feinberg School of Medicine
      Taia T. Wang, MD, PhD
      Stanford University School of Medicine
      Marc Nathan Wein, MD, PhD
      Harvard Medical School, Massachusetts General Hospital
      Craig Brian Wilen, MD, PhD
      Yale School of Medicine
      Michael Robert Wilson, MD, MAS
      University of California, San Francisco, School of Medicine
      Graeme F. Woodworth, MD
      University of Maryland School of Medicine
      Kelley Yan, MD, PhD
      Columbia University Vagelos College of Physicians and Surgeons
      Dmitriy Zamarin, MD, PhD
      Icahn School of Medicine at Mount Sinai
      Lilei Zhang, MD, PhD
      Baylor College of Medicine

      Please join us in congratulating these newly elected members!

      Nominations open for 2025 Honorary membership

      Posted on by John Hawley

      The ASCI is pleased to call for nominations for 2025 Honorary membership. Nominees for this recognition must fit the criteria as given in the ASCI bylaws:

      Any distinguished person who has contributed significantly to the Society’s objectives, who has not been previously and unsuccessfully nominated for Active or International membership, and who enjoys an unimpeachable moral standing is eligible for nomination in this category.

      For the nominee who meets these criteria, there is no restriction on age or degree held.

      The deadline for receipt of nominations is February 14, 2025, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations and submits its recommendations to Active and Senior members for approval.

      The nominator must be an ASCI member in good standing and must start the nomination:

      • Access your member account
      • Go to the “Nominations” tab, then to the “Honorary membership nomination” section
      • Select “I’m the nominator” option
      • Search for your nominee:
        • If found, click on “Start nomination”
        • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Start nomination” for the newly created nominee in the “Results” section
      • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
      • Provide a 250-word limit statement on the nominee’s qualifications
      • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

      The nominee receives an email with information to access their part of the nomination and then must:

      • Provide a birth date and address information
      • Provide a brief (300-word limit) biography
      • Provide current institutional affiliation
      • Upload a full curriculum vitae
      • Complete a demographics survey
      • Identify research domain(s)
      • Submit this aspect of the nomination, which can be done regardless of whether the nominator or supporter has completed their statement

      Announcing the ASCI PSSF Fellowship Program

      Posted on by John Hawley

      The American Society for Clinical Investigation (ASCI) is proud to announce its partnership with the Physician Scientist Support Foundation (PSSF), and the establishment of the ASCI PSSF Fellowship Program. 

      Recognizing the shared goal to bolster and sustain the pipeline of scholars entering the workforce, the ASCI has assumed the PSSF, positioning itself to expand innovative training pathways for emerging physician-scientists.

      The newly established ASCI PSSF Fellowship Program – formerly the PSSF Medical Student Research Fellowship (MSRF) – will continue to provide single-degree medical students with a one-year, rigorous training experience in biomedical research, guided by dedicated mentors. An eligible candidate must be a single-degree medical student interested in a dual career in research and patient care. They may not be enrolled in a combined degree program.

      The ASCI PSSF Fellowship includes:

      • A $42,000 stipend and an additional allowance of $8,000 for health insurance and travel expenses.
      • Complimentary registration and inclusive program access to the AAP/ASCI/APSA Joint Meeting.
      • 1:1 quarterly conversations with PSSF Advisory Committee mentors.
      • Access to ASCI’s virtual community programming including bi-monthly scientific seminars led by ASCI members and additional networking, enrichment, and career development activities.

      A key outcome of the merger was the establishment of the ASCI’s PSSF Advisory Committee, now comprising former PSSF’s founders and Board members. Guided by the ASCI Council, this group will remain dedicated to physician-scientist research as ambassadors of the ASCI PSSF Fellowship and mentors to its recipients. The Advisory Committee members are:

      For information or questions, please contact us at programs@the-asci.org.

      Nominations open for the 2025 Seldin~Smith Award for Pioneering Research

      Posted on by John Hawley

      The ASCI is pleased to call for nominations for the 2025 Seldin~Smith Award for Pioneering Research. The annual award, accompanied by an unrestricted $30,000 grant to advance academic efforts, honors an early-career physician-scientist who has demonstrated exceptional creativity and accomplishments in biomedical research (see past recipients).

      The deadline for receipt of nominations is Wednesday, November 13, at 11:59 pm Eastern.

      The nominee:

      • must be an MD (or the equivalent);
      • must be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment as of April 2025; and
      • spends substantial time in research while providing direct patient care.

      A nomination must be started by the nominator, who then notifies the nominee to complete her/his part of the nomination. The nominee identifies the supporter of the nomination and notifies that person through the submission site to complete her/his support form. Note: The nominee may not be a past recipient of the Foundation for the NIH’s Trailblazer Prize for Clinician-Scientists.

      Nominations will be screened to ensure they are complete and fit the nomination criteria. The Seldin~Smith Award Selection Committee reviews nominations and provides recommendations to the Seldin~Smith Award Advisory Committee to determine the recipient.

      The nominator must be an ASCI member in good standing and must start the nomination:

      • Access your member account
      • Go to the “Nominations” tab, then to the “ASCI / Seldin~Smith Award for Pioneering Research” section
      • Select “I’m the nominator” option
      • Search for your nominee:
        • If found, click on “Create nomination”
        • If no result is found, provide and save the requested information (first name, last name, and email address), then click on “Create nomination” for the newly created nominee in the “Results” section
      • At the top of the nomination form, click on “Send access notification to the nominee at: <email>”
      • Provide a 500-word limit statement on the nominee’s most significant achievement
      • Submit the statement, which can be done regardless of whether the nominee’s part of the nomination is completed

      The nominee receives an email with information to access her/his part of the nomination and then must:

      • Provide a birth date and address information
      • Provide a summary (100-word limit) of her/his research, followed by a notation of the percentage of time devoted to direct patient care
      • Provide detail of:
        • Degrees obtained
          • Year of first faculty or equivalent appointment
        • Current institutional affiliation
      • Upload:
        • Current NIH-style biosketch
        • Three significant publications, each with an annotation (100-word limit)
      • Identify the nomination’s supporter and send notification to the supporter to access her/his support form
      • Complete a demographics survey
      • Identify research domain(s)
      • Submit this aspect of the nomination, which can be done regardless of whether the nominator or supporter has completed her/his statement

      The supporter:

      • Does not need to be an ASCI member
      • Must be identified and notified by the nominee
      • Provides a statement (500-word limit) of the nominee’s research contributions (the statement should be distinct from that of the nominator)

      Nominations open for mid-career member awards, 2025

      Posted on by John Hawley

      The ASCI is pleased to call for nominations for awards recognizing the scholarly achievements of mid-career members:

      The Marian W. Ropes, MD, Award recognizes a middle-career woman physician-scientist. The annual award honors Dr. Ropes (1903–1994), a pioneer both as a researcher on the role of synovial fluid in joint diseases and as a woman in academic medicine. She was the first woman documented to have been elected to the ASCI. The recipient of this award will receive a $10,000 honorarium, be recognized at the ASCI’s 2025 annual meeting, and give the Ropes Lecture at the 2026 meeting.

      The Louis W. Sullivan, MD, Award recognizes a middle-career physician-scientist from a population underrepresented in medicine and science. The award honors Dr. Sullivan (born 1933), a hematologist, health care advocate, and policy leader — having served as US Secretary of Health and Human Services — and who was the first Black physician-scientist elected to the ASCI. The recipient of this award will receive a $10,000 honorarium, be recognized at the ASCI’s 2025 annual meeting, and give the Sullivan Lecture at the 2026 meeting.

      ASCI members who were elected in 2020 or more recently may be nominated. Additionally:

      • For the Ropes Award, only female members are eligible for nomination.
      • For the Sullivan Award, only UiMS members are eligible for nomination.

      The deadline for receipt of nominations is November 4, 2024, at 11:59 pm Eastern. Nominations will be screened to ensure they are complete and fit the award criteria. The ASCI’s Diversity, Equity, and Inclusion Committee will review nominations and submit recommendations to the ASCI Council for approval. We expect to notify nominees about the outcome by mid-December 2024.

      Nominators:

      • must be ASCI members; current members of the ASCI Council and Diversity, Equity, and Inclusion Committee are excluded; and
      • must provide a statement regarding the nominee (500-word limit).

      Nominees:

      • must fit the criteria noted above and may not be current members of the ASCI Council and/or Diversity, Equity, and Inclusion Committee;
      • may be nominated for only one ASCI award (for example, a nominee for the Ropes Award may not be nominated for the Sullivan Award, Korsmeyer Award, Harrington Prize, or Scharschmidt~Crawford Award);
      • must provide the following:
        • a personal statement (750-word limit) on their scientific achievements, with attention to relevant personal and career history (including a statement on diversity), mentoring experience, and service to the community;
        • a full curriculum vitae; and
        • 3 most-significant publications, each with a 50-word annotation, followed by the member’s role in the publication, the journal name and publication year, and the Pubmed ID noted as “PMID:12345”;
      • must complete the ASCI’s demographics survey; and
      • must provide information regarding their research domain(s).

      To start a nomination:

      • Access your member account
      • Go to the “Nominations” tab
      • In the section for the award of interest:
        • If you are the nominee, select the “I’m the nominee” option to start your part of the nomination (only you have access to this information); note that in the case of the Ropes Award, this option will not be available for male members.
        • If you are the nominator, select “I’m the nominator” option, then search for your nominee. Only nominees who were elected starting 2020 will appear in the results. Note: for the Ropes Award, you will only be able to select a nominee who is a woman; for the Sullivan Award, you may select anyone who is within the election-year window, but nominations will be screened (based on the information the nominee provides in the demographics survey) to ensure they fit the UiMS criterion.

      Definition of UiMS

      The ASCI defines underrepresented in medicine in science as follows: Underrepresented in medicine and science (UiMS) refers to populations that are underrepresented relative to their numbers in the general US population. This includes, but is not necessarily limited to, physician-scientists who identify in the following racial and/or ethnic groups: Black/African American, Hispanic or Latin American, Native American/American Indian or Alaska Native, and Native Hawaiian and other Pacific Islander; individuals with disabilities: physical or mental impairment that substantially limits one or more major life activities; and those with an educationally or financially disadvantaged background.

      Nominations open for the 2025 ASCI / Stanley J. Korsmeyer Award

      Posted on by John Hawley

      Nominations for the ASCI’s 2025 ASCI / Stanley J. Korsmeyer Award are now open.

      This prestigious recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Award recognizes individuals for their advancement of knowledge in a specific field and for mentoring future generations of life science researchers. Information on all past honorees is available here.

      The Awardee delivers the Korsmeyer Award Lecture at the 2025 AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium.

      Current Active and International ASCI members are eligible for nomination. Prior nominees who remain eligible may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

      The deadline for receipt of nominations is October 31, 2024, at 11:59 pm Eastern (extended from October 23). Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected toward the end of November 2024.

      Nominators:

      • may be any ASCI member in good standing, including members of the Council;
      • must provide a statement (250-word limit) regarding the nominee; and
      • must comment regarding other investigators who have significantly contributed to the discoveries related to the nomination.

      Nominees:

      • must currently be an Active or International member (age 55 or younger);
      • must provide a biosketch, full curriculum vitae, and a trainee table;
      • must identify a former mentee to provide a statement of support (500-word limit);
      • must complete the ASCI’s demographic survey; and
      • must identify their research domain(s).

      To start a nomination:

      Nominations may be started by the nominator or the nominee:

      • Access your member account
      • Go to the “Activities / nominations” tab
      • Go to the section for “ASCI / Stanley J. Korsmeyer Award”

      For the nominator:

      • Select “I’m the nominator” option
      • Search for your nominee
      • Click on “Start nomination”
      • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
      • Supply the required information (see above)
      • Submit this aspect of the nomination

      For the nominee:

      • Select “I’m the nominee” option
      • Supply the required information (see above)
      • Submit this aspect of the nomination

      Nominations open for the 2025 ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award

      Posted on by John Hawley

      Nominations for the ASCI’s 2025 Bruce F. Scharschmidt & Peggy S. Crawford Translational Medicine Distinguished Lectureship and Award are now open.

      The Award recognizes those who have made important contributions to the development of high-impact diagnostics or therapeutics for patients. The Awardee delivers the Scharschmidt~Crawford Distinguished Lectureship at the annual AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium. Drs. Scharschmidt and Crawford have pledged a very generous philanthropic gift to the ASCI to fully endow the Award, the first of which will be presented at the 2025 Joint Meeting, April 25-27.

      Any person with an MD or equivalent, regardless of ASCI membership, is eligible for nomination. However, current ASCI Council members may not be nominated.

      The deadline for receipt of nominations is October 31, 2024, at 11:59 pm Eastern (extended from October 23). Nominations will be screened to ensure they are complete and fit the nomination criteria. The Council reviews nominations, with the outcome of review expected in December 2024.

      Nominators:

      • may be any ASCI member in good standing, including members of the Council, and
      • must provide a statement (250-word limit) regarding the nominee.

      Nominees:

      • may be any person with an MD or equivalent, regardless of ASCI membership, but excluding members of the Council;
      • must be able to attend the 2025 Joint Meeting, April 25-27, in Chicago;
      • must provide a 500-word-limit description of their contributions to the development of high-impact diagnostics or therapeutics for patients;
      • must provide a full curriculum vitae;
      • must complete the ASCI’s demographic survey; and
      • must provide information regarding their research domain(s).

      To start a nomination:

      Nominations may be started by the nominator or the nominee:

      • Access your member account
      • Go to the “Activities / nominations” tab
      • Go to the section for “ASCI / Scharschmidt~Crawford Distinguished Lectureship and Award”

      For the nominator:

      • Select “I’m the nominator” option
      • Search for your nominee
      • Click on “Start nomination”
      • If the nominee has not already claimed her/his part of the nomination, click on “Send nominee information to access the nominee’s part of the nomination” to send the nominee an email to access and edit her/his aspect of the nomination (see above).
      • Supply the required information (see above)
      • Submit this aspect of the nomination

      For the nominee:

      … if the nominee is an ASCI member:

      • Select “I’m the nominee” option
      • Supply the required information (see above)
      • Submit this aspect of the nomination

      … if the nominee is not ASCI member, the nominee can email staff@the-asci.org to have a nomination set up by staff.

      Announcing the Scharschmidt~Crawford Translational Medicine Distinguished Lectureship and Award

      Posted on by John Hawley

      The ASCI is honored to announce a new recognition for its community: the Bruce F. Scharschmidt & Peggy S. Crawford Translational Medicine Distinguished Lectureship and Award, which recognizes important contributions to the development of high-impact diagnostics or therapeutics for patients.

      The Awardee delivers the Scharschmidt~Crawford Distinguished Lectureship at the annual AAP/ASCI/APSA Joint Meeting and receives an unrestricted $20,000 honorarium. Drs. Scharschmidt and Crawford have pledged a very generous philanthropic gift to the ASCI to fully endow the Award, the first of which will be presented at the 2025 Joint Meeting.

      The ASCI will begin accepting nominations for the inaugural Award on September 5, with full details on eligibility criteria and the nomination process provided at that time.

      About Drs. Scharschmidt and Crawford

      Dr. Scharschmidt was elected to the ASCI in 1982. He served as the 1987-1992 Editor-in-Chief of the Journal of Clinical Investigation and as the ASCI’s 1992-1993 President. He attended Northwestern University’s Undergraduate School and Northwestern University’s Feinberg School of Medicine (NUFSM) and finished his postgraduate training at the National Institutes of Health and the University of California, San Francisco (UCSF). He then served as Professor of Medicine and Chief of Gastroenterology at UCSF, where he and colleagues launched the UCSF liver-transplant program. In 1996 he was recruited to Chiron to head clinical development and biometrics. He was most recently Chief Medical and Development Officer at Hyperion Therapeutics where he oversaw the development of glycerol phenylbutyrate (GPB), an ammonia-lowering agent, which was approved for the treatment of urea-cycle disorders and which achieved success in a phase 2 trial for hepatic encephalopathy.

      Dr. Scharschmidt has authored over 200 research and review articles, is inventor/co-inventor on multiple patents, and has published several children’s picture books intended as a fun and early introduction to science. He served as Editor of Sleisenger & Fordtran’s Textbook of Gastroenterology, on the National Board of Directors of the American Liver Foundation, on the President’s Council of UCSF’s J. David Gladstone Institutes, and as mentor to colleagues in academia and industry. He served on the External Advisory Board for the NUFSM Clinical and Translational Science Award (2008-2021), was named Distinguished NUFSM Alumnus in 2010, served as President of the NUFSM Medical Alumni Board (2015-2017), and received the prestigious Service to Northwestern Award in 2018. He has raised over $100,000 for multiple foundations, including the American Liver Foundation, the Karen Department of Health and Welfare (a Myanmar welfare organization for which he and his son organized a fund-raiser bike ride from central Thailand to the Myanmar border), and the National Urea Cycle Disorders Foundation.

      Dr. Crawford has devoted her career to the care of her patients and mentoring the next generation of dermatologists. She graduated from Northwestern’s Feinberg School of Medicine, where she also completed a rotating medical internship. She did further post-graduate training with Dr. Steven Katz in the Dermatology Branch of the NIH and completed her Dermatology Residency at UCSF. Afterward, she joined the Kaiser Permanente Medical Group of Northern California. She has served as Clinical Professor of Dermatology on the UCSF volunteer faculty, where she helped mentor and teach a generation of UCSF dermatology residents.

      Dr. Crawford has been recognized multiple times as Community Faculty Awardee of the Year by the dermatology residents at UCSF, where she served as member and Chair of the Clinical Faculty Promotions Committee. She has also served on the Board of The Women’s Dermatologic Society, has been an awardee of the Mediterranean Academy of Women in Dermatology, and is a recipient of the Dermatology Foundation’s prestigious Clark W. Finnerud Award, given annually to one U.S. dermatologist who demonstrates exemplary service as a practitioner and teacher.

      Drs. Scharschmidt and Crawford have two children: Brent Scharschmidt, MD, is a family medicine physician at the Permanente Medical Group of Northern California and Tiffany Scharschmidt, MD (elected to the ASCI in 2024), is Professor in the UCSF Department of Dermatology, where she currently serves as Vice Chair for Research.